Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin

Tatsuro Jo(Japanese Red Cross Society, Japan), Kazuto Shigematsu(Japanese Red Cross Society, Japan), Jun Taguchi(Japanese Red Cross Society, Japan), Kaori Matsuzaka(Japanese Red Cross Society, Japan), Haruna Shioya(Japanese Red Cross Society, Japan), Takahiro Sakai(Japanese Red Cross Society, Japan), Masatoshi Matsuo(Japanese Red Cross Society, Japan), Hiro-o Tominaga(Japanese Red Cross Society, Japan), Shizuka Hayashi(Japanese Red Cross Society, Japan), Yohei Kaneko(Japanese Red Cross Society, Japan), Kuniko Abe(Japanese Red Cross Society, Japan)
Case Reports in Oncology
November 30, 2020
Cited by 4


Related Papers